Lifecore Biomedical [LFCR] vs Haleon Plc - ADR [HLN] Detailed Stock Comparison

Lifecore Biomedical Inc.

NASDAQ
Loading...

Haleon Plc - ADR

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Lifecore Biomedical Inc. wins in 4 metrics, Haleon Plc - ADR wins in 16 metrics, with 0 ties. Haleon Plc - ADR appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Lifecore Biomedical Inc. Haleon Plc - ADR Better
P/E Ratio (TTM) 56.23 18.72 Haleon Plc - ADR
Price-to-Book Ratio -17.45 1.88 Haleon Plc - ADR
Debt-to-Equity Ratio 414.80 52.37 Haleon Plc - ADR
PEG Ratio -1.24 15.42 Haleon Plc - ADR
EV/EBITDA 44.66 33.08 Haleon Plc - ADR
Profit Margin (TTM) -23.78% 15.11% Haleon Plc - ADR
Operating Margin (TTM) 8.18% 23.17% Haleon Plc - ADR
EBITDA Margin (TTM) 8.18% 23.17% Haleon Plc - ADR
Return on Equity 312.34% 10.27% Lifecore Biomedical Inc.
Return on Assets (TTM) -19.11% 4.67% Haleon Plc - ADR
Free Cash Flow (TTM) $-13.62M $2.22B Haleon Plc - ADR
Dividend Yield N/A 1.63% N/A
1-Year Return -25.85% -20.18% Haleon Plc - ADR
Price-to-Sales Ratio (TTM) 1.51 3.78 Lifecore Biomedical Inc.
Enterprise Value $368.08M $122.54B Haleon Plc - ADR
EV/Revenue Ratio 2.84 8.23 Lifecore Biomedical Inc.
Gross Profit Margin (TTM) 25.04% 55.38% Haleon Plc - ADR
Revenue per Share (TTM) $3 $2 Lifecore Biomedical Inc.
Earnings per Share (Diluted) $-1.27 $0.50 Haleon Plc - ADR
Beta (Stock Volatility) 0.88 0.33 Haleon Plc - ADR
Short % of Float 12.08% 0.43% Haleon Plc - ADR

Lifecore Biomedical Inc. vs Haleon Plc - ADR Stock Performance Analysis

Loading Price Chart...

LFCR
HLN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Lifecore Biomedical Inc.4.22%13.75%6.43%-24.48%-29.27%-29.46%
Haleon Plc - ADR0.23%-5.84%-5.84%-19.96%-10.03%-13.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Lifecore Biomedical Inc.-25.85%-38.40%-60.63%-55.14%-16.19%-44.53%
Haleon Plc - ADR-20.18%9.16%22.27%22.27%22.27%22.27%

Performance & Financial Health Analysis: Lifecore Biomedical Inc. vs Haleon Plc - ADR

MetricLFCRHLN
Market Information
Market Cap i$184.39M$42.40B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i368,9726,594,249
90 Day Avg. Volume i505,5347,985,230
Last Close$5.68$8.72
52 Week Range$3.63 - $8.98$8.65 - $11.30
% from 52W High-36.75%-22.83%
All-Time High$20.75 (May 20, 1996)$11.42 (Jun 02, 2025)
% from All-Time High-72.63%-23.64%
Growth Metrics
Quarterly Revenue Growth-0.15%0.01%
Quarterly Earnings Growth0.26%0.86%
Financial Health
Profit Margin (TTM) i-0.24%0.15%
Operating Margin (TTM) i0.08%0.23%
Return on Equity (TTM) i3.12%0.10%
Debt to Equity (MRQ) i414.8052.37
Cash & Liquidity
Book Value per Share (MRQ)$-0.38$4.99
Cash per Share (MRQ)$0.47$0.15
Operating Cash Flow (TTM) i$12.57M$3.56B
Levered Free Cash Flow (TTM) i$163.59M$1.89B
Dividends
Last 12-Month Dividend Yield iN/A1.63%
Last 12-Month Dividend iN/A$0.17

Valuation & Enterprise Metrics Analysis: Lifecore Biomedical Inc. vs Haleon Plc - ADR

MetricLFCR (Apr 24, 2026)HLN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i56.2318.72
Forward P/E i-6.3015.42
PEG Ratio i-1.2415.42
Price to Sales (TTM) i1.513.78
Price to Book (MRQ) i-17.451.88
Market Capitalization
Market Capitalization i$184.39M$42.40B
Enterprise Value i$368.08M$122.54B
Enterprise Value Metrics
Enterprise to Revenue i2.848.23
Enterprise to EBITDA i44.6633.08
Risk & Other Metrics
Beta i0.880.33
Book Value per Share (MRQ) i$-0.38$4.99

Financial Statements Comparison: Lifecore Biomedical Inc. vs Haleon Plc - ADR

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricLFCR (2025)HLN (2025)
Revenue/Sales i128.87M11.03B
Cost of Goods Sold i88.57M3.95B
COGS % of Revenue i68.7%35.8%
Gross Profit i40.30M7.08B
Gross Margin i31.3%64.2%
Research & Development i8.26M316.00M
Operating Income (EBIT) i-12.01M2.41B
Operating Margin i-9.3%21.9%
EBITDA i-3.65M2.81B
EBITDA Margin i-2.8%25.5%
Pre-Tax Income i-38.67M2.15B
Pre-Tax Income % of Revenue i-30.0%19.5%
Income Tax i43,000472.00M
Income Tax % of Revenue i0.0%4.3%
Net Income (Profit) i-38.72M1.68B
Profit Margin i-30.0%15.2%

Balance Sheet & Liquidity Metrics

MetricLFCR (2025)HLN (2025)
Cash & Equivalents i17.47M1.26B
Total Current Assets i82.29M4.55B
Total Current Assets % of Revenue i63.9%41.3%
Total Current Liabilities i23.57M4.93B
Total Current Liabilities % of Revenue i18.3%44.7%
Long-Term Debt i141.28M7.75B
Long-Term Debt % of Revenue i109.6%70.2%
Total Shareholders Equity i-14.20M16.48B
Retained Earnings i-223.20M27.85B
Retained Earnings % of Revenue i-173.2%252.5%
Property, Plant & Equipment i01.00M

Cash Flow Statement Comparison

MetricLFCR (2025)HLN (2025)
Operating Cash Flow i-1.65M2.19B
Operating Cash Flow % of Revenue i-1.3%19.8%
Capital Expenditures i-6.42M-322.00M
Free Cash Flow i-13.62M2.22B
FCF Margin i-10.6%20.1%
Debt Repayment i-145.76M-1.35B
Common Stock Repurchase iN/A-654.00M

Short Interest & Institutional Ownership Analysis

MetricLFCRHLN
Shares Short i2.59M19.28M
Short Ratio i5.492.14
Short % of Float i12.08%0.43%
Shares Outstanding i37.47M8.91B
Float Shares i19.84M8.86B
% Held by Insiders i1.92%0.01%
% Held by Institutions i76.45%12.74%
% Held by Public i21.63%87.25%

Dividend Analysis & Yield Comparison: Lifecore Biomedical Inc. vs Haleon Plc - ADR

MetricLFCRHLN
Last 12-Month Dividend iN/A$0.17
Last 12-Month Dividend Yield iN/A1.63%
3-Year Avg Annual Dividend iN/A$0.11
3-Year Avg Dividend Yield iN/A0.91%
3-Year Total Dividends iN/A$0.34
Ex-Dividend DateN/AApr 25, 2025